Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: A 12-week, randomized, double-blind, placebo-controlled trial

Crisanto Diez-Quevedo, Helena Masnou, Ramon Planas, Pere Castellví, Dolors Giménez, Rosa M. Morillas, Rocío Martin-Santos, Ricard Navinés, Ricard Solà, Pilar Giner, Mercè Ardèvol, Joan Costa, Moisés Diago, Juan Pretel

Research output: Contribution to journalArticleResearchpeer-review

35 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: A 12-week, randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences